Quantcast

Psychiatric Drugs For Children Approved By Expert Panel

June 11, 2009

Although psychiatric drugs in children and adolescents can increase the risk of diabetes, Food and Drug Administration advisers still claim the drugs seem safe and effective for treatment of certain conditions, the Associated Press reported. 

Drugs by AstraZeneca, Eli Lilly and Pfizer are seemingly safe and beneficial for the treatment of schizophrenia and bipolar disorder in individuals ages 10 to 17, according to an overwhelmingly supportive vote by the FDA’s panel of experts. 

Adult use of the drug has already been approved for those suffering schizophrenia and bipolar disorder. 

Typically, the FDA will make judgments in favor of the group’s recommendation, although it is not mandatory. 

If the FDA agrees to the group’s advice, the use of the drugs, which already make up the leading class of prescriptions in the US, would increase significantly.  Sales in 2008 equaled $14.6 billion, according to health care analysis firm IMS Health. 

On the Net:




comments powered by Disqus